- Published on
KembaraXtra – Medicine – Ménière Disease
Ménière disease is a chronic disorder of the inner ear characterized by recurrent, spontaneous episodes of vertigo accompanied by sensorineural hearing loss, tinnitus, and a sensation of aural fullness. The condition most commonly affects one ear, although bilateral involvement may occur in up to 40% of patients. The estimated incidence is approximately 15 per 100,000 people in the United States, with a slight female predominance. Although Ménière disease can occur at any age, it most frequently presents between 40 and 60 years of age. While benign and nonfatal, it can lead to significant morbidity due to the unpredictability and severity of symptoms.
The etiology of Ménière disease is idiopathic, with endolymphatic hydrops considered the primary underlying mechanism. This condition results from impaired drainage of endolymph from the endolymphatic sac and duct, leading to increased pressure within the endolymphatic system. Elevated pressure may cause rupture of the membrane separating potassium-rich endolymph from potassium-poor perilymph, resulting in abnormal stimulation and transient dysfunction of vestibular and cochlear nerve receptors. Additional proposed contributors include structural abnormalities of the endolymphatic system, autoimmune processes, genetic predisposition, remote viral injury, and ischemia of the inner ear. It is important to distinguish Ménière disease from secondary Ménière syndrome caused by conditions such as thyroid disease, syphilis, autoimmune inner ear disease, or medication effects.
Diagnosis is based primarily on clinical features supported by neurotologic evaluation. Definitive diagnosis requires histopathologic confirmation and therefore can only be made postmortem, though modern MRI techniques may provide supportive evidence. Diagnostic criteria include at least two spontaneous episodes of vertigo lasting 20 minutes or longer, at least one documented episode of sensorineural hearing loss on audiometric testing, and the presence of tinnitus or aural fullness in the affected ear. Based on the completeness of findings, cases are categorized as definite, probable, or possible Ménière disease.
Patients typically present with the classic tetrad of vertigo, hearing loss, tinnitus, and aural fullness. Vertigo attacks last from minutes to hours and are frequently associated with nausea and vomiting. Hearing loss is sensorineural, fluctuating, and progressive, often initially affecting low frequencies before potentially involving all frequencies over time. Tinnitus is commonly low-pitched and described as roaring, while aural fullness is perceived as pressure or congestion in the affected ear. Attacks usually reach peak intensity rapidly and resolve gradually, leaving patients fatigued and unsteady for hours to days. Some individuals may be asymptomatic between episodes, while others experience persistent imbalance. Sudden drop attacks without loss of consciousness may also occur.
Physical examination findings vary depending on whether the patient is evaluated during or between attacks. During acute episodes, patients may appear pale, diaphoretic, and distressed. Horizontal nystagmus and impaired hearing are commonly observed. Tuning fork testing often reveals lateralization away from the affected ear on Weber testing, with preserved air conduction on Rinne testing. Romberg testing may demonstrate postural instability, particularly with eyes closed. A thorough neurologic and otologic examination is essential to exclude central nervous system pathology or alternative peripheral ear disorders.
The essential evaluation includes a detailed history and complete neurologic examination. Neuroimaging is warranted when central causes of vertigo are suspected or when focal neurologic deficits are present, particularly in patients with new unilateral hearing loss. Audiometric testing is critical for documenting sensorineural hearing loss, and additional vestibular studies such as caloric testing, electronystagmography, or electrocochleography are typically performed in the outpatient setting. Laboratory investigations are reserved for suspected systemic or secondary causes.
Management in the acute setting focuses on symptom control and exclusion of life-threatening conditions such as stroke. Patients should be protected from falls and maintained in a comfortable position. Intravenous fluids are indicated for dehydration due to vomiting. Benzodiazepines and antiemetics are first-line therapies for acute vertigo and nausea, with antihistamines used as adjuncts. Long-term management aims to reduce the frequency and severity of attacks through dietary sodium restriction, avoidance of triggers such as caffeine and alcohol, diuretics, corticosteroids, and selected transtympanic therapies. Surgical interventions are reserved for patients with severe, refractory disease.
Disposition depends on symptom severity and response to treatment. Admission is indicated for patients with intractable vertigo, persistent vomiting, dehydration, or inability to ambulate safely. Most patients can be discharged once symptoms are controlled, oral intake is tolerated, gait is stable, and neurologic examination is normal. Discharged patients should receive fall precautions and counseling to avoid driving or hazardous activities until symptoms have resolved and sedating medications have been discontinued. Outpatient follow-up with otolaryngology, otology, or neurology is recommended for further evaluation, audiometry, and long-term management.
0 Comments
